This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.3181/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74311657
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en payares de 1956 im November 1956 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 November 1956 wetenschappelijk artikel 1956 թվականի նոյեմբերի 1-ին հրատարակված գիտական հոդված наукова стаття, опублікована в листопаді 1956
p:P577
wds:Q74311657-6CD3FF58-1A2B-4918-AA17-894CAAC3A747
wdt:P577
1956-11-01T00:00:00Z
p:P2093
wds:Q74311657-CC5B0D68-F4F0-4840-A74D-8471CBC8D639 wds:Q74311657-C30327C0-E2FB-404A-8640-A950C9EF1325 wds:Q74311657-0427980F-45FA-41FD-983F-FF6EC2F3ED9C
wdt:P2093
R L NICHOLS W F JONES M FINLAND
rdfs:label
Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin
skos:prefLabel
Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin
schema:name
Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin
p:P1476
wds:Q74311657-99A69272-8AA7-4B2E-BBBA-A00ADF9123B5
wdt:P1476
Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin
p:P304
wds:Q74311657-97196F2A-5608-4958-B631-FAEAA87990D5
wdt:P304
388-393
p:P31
wds:Q74311657-063287F1-7ECF-43E6-BF52-349C0C256EB5
wdt:P31
wd:Q13442814
p:P921
wds:Q74311657-3001638F-DA64-4B54-8958-ED8FE7E69F2E
wdt:P921
wd:Q213511
p:P698
wds:Q74311657-C8A8D1AF-ED0D-46BB-92C9-4C80993E6F98
wdtn:P698
n8:13379520
wdt:P698
13379520
p:P1433
wds:Q74311657-264A9FDB-6EDA-421A-A5BA-4D4BAE817ECD
wdt:P1433
wd:Q45038026
p:P433
wds:Q74311657-A9304DD9-5435-433C-902B-9B16C21E9AF8
p:P478
wds:Q74311657-1472A0B7-0735-41A3-80D2-098E961582DE
wdt:P433
2
wdt:P478
93
p:P356
wds:Q74311657-BC18DBCA-E244-4BB0-8B0A-59729BE729A7
wdtn:P356
n12:00379727-93-22766
wdt:P356
10.3181/00379727-93-22766